Foreign object infections
Introduction
FDA data shows that chronic health problems are reduced in most patients who decide to have their breast implants removed (explantation). Nonetheless, breast implant illness (BII) is a controversial illness as many doctors do not believe that breast implants can lead to the development of chronic health problems. Despite presenting data on health outcomes following explantation, the FDA notes that "BII is not recognized as a formal medical diagnosis".
There is currently no test to detect BII and no test that can help predict the outcome of explantation.
FDA data
Outcomes
Of the 3,577 MDRs [Medical Device Reporting reports], 1535 (or 43%) reported the patient undergoing device explant at some time following the onset of symptoms. Of these, 1,473 reports provided information sufficient to calculate the time from implantation to explant. The average time to explant was 9 years, with a range of 0- 47 years. Only 290 MDRs provided information related to the status of a woman’s symptoms following explant. Of these, 279 noted improvement and 11 noted either no improvement or worsening of symptoms.
Most common systemic signs or symptoms
| Symptom | Percentage of MDRs (N=3,577) |
|---|---|
| Fatigue | 49% |
| "Brain Fog" | 25% |
| Joint Pain | 25% |
| Anxiety | 24% |
| Hair Loss | 21% |
| Depression | 19% |
| Rash | 18% |
| Autoimmune Diseases (incl. symptoms of autoimmune disease) | 18% |
| Inflammation | 18% |
| Weight Fluctuation | 18% |
Breast Implant Illness: A Biofilm Hypothesis https://dx.doi.org/10.1097%2FGOX.0000000000002755
Data on breast implant illness
https://www.fda.gov/medical-devices/breast-implants/medical-device-reports-systemic-symptoms-women-breast-implants https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8342259/
Need to add article on ASIA syndrome
siliconosis